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Abstract. In this work, we present a novel convolutional neural net-
work based method for perfusion map generation in dynamic suscepti-
bility contrast-enhanced perfusion imaging. The proposed architecture is
trained end-to-end and solely relies on raw perfusion data for inference.
We used a dataset of 151 acute ischemic stroke cases for evaluation. Our
method generates perfusion maps that are comparable to the target maps
used for clinical routine, while being model-free, fast, and less noisy.
1 Introduction
Dynamic susceptibility contrast-enhanced (DSC) magnetic resonance imaging
(MRI) is an essential tool to assess perfusion deficits in acute ischemic stroke
[6]. Given a perfusion sequence, traditional methods rely on an estimation of
the arterial input function (AIF) and on a parametric model to generate perfu-
sion maps. Automatic estimation of the AIF tends to be non-robust, whereas a
manual selection of the AIF is impractical. Besides, the computation of perfu-
sion maps costs time in the range of minutes, in situations where time is often
critical.
In 2017, Song et al. [7] introduced temporal similarity perfusion (TSP) maps,
together with a model-free, iterative process for their generation. The generated
maps are compared to traditional time-to-peak (TTP) and mean-transit-time
(MTT) maps to assess their clinical value for the detection of perfusion deficits.
The proposed method operates without the need for AIFs, but it is fixed to the
generation of TSP maps. Machine learning has been used extensively to post-
process perfusion maps, e.g., to estimate tissue at risk (penumbra) [4]. Mean-
while, in McKinley et. al [5] regression of perfusion maps from raw DSC-MRI
perfusion data in the presence of an externally provided AIF was demonstrated.
Fully automatic end-to-end regression of DSC perfusion maps has not been ap-
proached so far.
In this paper, we present a model-free, convolutional neural network (CNN)
based architecture to predict arbitrary perfusion maps in an end-to-end manner.
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There have already been applications of CNNs on dynamic contrast-enhanced
(DCE) perfusion sequences [8]. However, our work is the first application on
DSC-MRI perfusion sequences to the best of our knowledge.
2 Methods
In this section, we describe the proposed neural network architecture for predict-
ing synthetic perfusion maps. Since the architectures we developed for predict-
ing different types of perfusion maps are similar (see supplemental material), we
solely focus on the one used for predicting Tmax perfusion maps.
2.1 Pre-Processing and Augmentation
We pre-process both the raw perfusion data and the target perfusion maps.
Each volume is padded with zeros to match the maximum size of any volume in
the training dataset. Additionally, the perfusion sequence is complemented with
volumes at the end to match the maximum sequence length of any perfusion
sequence in the training dataset. For this, we reflect the data to generate frames
for padding instead of using zero-filled volumes. The resulting perfusion maps
are of size 24 × 256 × 256, the perfusion sequences of size 80 × 24 × 256 × 256,
where 80 is the number of frames and 24 the number of image slices.
After padding, we perform data standardization, i.e., we transform the data,
so it has zero mean and unit variance. Finally, we apply voxel-wise temporal
Gaussian smoothing for the perfusion sequence with σt = 1.0.
From inspecting the training portion of our dataset, we conclude that the
time of perfusion sequence start is not in a global relation to the time of bolus
arrival in the brain, i.e., there are cases where the bolus arrives much earlier or
later than in most other cases. Even though such cases occur rarely, we want our
model to be able to handle arbitrary delays of the bolus. To prevent the model
from learning a global bolus arrival time, we augment the training dataset by
randomly offsetting the perfusion sequence by -5 to 30 frames. A negative number
means we remove frames at the beginning of the sequence and add padding
frames at the end, a positive number indicates the opposite. The padding is
generated via reflecting.
2.2 Deep Architecture for Perfusion Map Regression
The goal is to predict voxel-values in a target perfusion map P based on the
raw perfusion sequence S. Our crucial assumption is that a voxel-value px,y,z in
perfusion map P mostly depends on the sequence of voxels at the same loca-
tion in the raw perfusion sequence, i.e., on s1:T,x,y,z, where T indicates the total
number of frames in the perfusion sequence. There are obvious limitations to
this assumption, which will be discussed in Section 4. Based on this assumption,
we use a CNN to capture the temporal evolution of the raw perfusion sequence
voxel-wise. Figure 1 shows an overview of our architecture. The individual sub-
structures will be briefly explained in the following sections.
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Fig. 1. An overview of the perfusion map prediction model.
Bolus Characterization. Our model has neither knowledge of the arterial
input function nor the time of bolus arrival in the brain. Ignoring these aspects
would significantly impair the performance of our model. Therefore, we add a
bolus characterization structure (BCS) which should help capture the time of
bolus arrival in the brain as well as the AIF. Guided by the fact that those
characteristics are captured best by large blood vessels entering the brain, we
select the input to the BCS to be a patch sequence from the perfusion sequence,
located at the transition between the basilar artery and the posterior cerebral
artery. The location of this patch is globally fixed, i.e., it is not fine-tuned to the
individual volume. Therefore, it may happen that this patch does not contain the
desired blood vessels for specific instances in our data. The BCS processes the
supplied patch sequence via two 3D convolutional layers, encoding each patch
into a vector of size 16. The sequence of encoded patches is forwarded to the
sequence encoder.
Sequence Encoding. The sequence encoder handles every voxel sequence
s1:T,x,y,z independently, together with the additional information supplied by
the bolus characterization structure. Note that this information is the same for
all s1:T,x,y,z of a perfusion sequence S. For simplicity, we will describe how the
sequence encoder handles one individual voxel sequence. In reality, the sequence
encoder processes multiple voxel sequences concurrently.
Effectively, the sequence encoder works on three inputs: a sequence of voxel-
values s1:T,x,y,z, the sequence of frame times ∈ R80, and the sequence of encoded
patches from the bolus characterization structure. These sequences are concate-
nated along their non-temporal dimension, resulting again in a sequence of length
80. This result is passed through three 1D convolutional layers, of which the first
two are followed by a max-pooling layer. The output is a vector of size 256, cap-
turing the evolution over time of one voxel in the perfusion sequence.
Spatial Correlation. So far, there is no flow of information between neigh-
boring voxels, i.e., each voxel sequence s1:T,x,y,z is handled independently. Due
to the low spatial resolution of the volumes along the axial axis, we omit spa-
tial correlation between slices. To allow for some learned local filtering within
slices, we apply 2D convolution to the voxel-wise output of the sequence encoder.
Figure 2 illustrates this process.
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Fig. 2. The architecture we used for local spatial correlation. The dense layer only
operates on the last dimension of the data. Note that the shape of the data passed from
the sequence encoder to the 2D convolution stems from the fact that we process the
volumes in patches of 1×32×256 and that each voxel sequence s1:T,x,y,z is encoded into
a vector of size 256. The first dimension of the data is redundant and is only depicted
for clarity. Selu denotes the activation function used [3].
Regression. Given the spatially correlated encoding of voxel sequence s1:T,x,y,z,
the prediction of the perfusion map voxel-value pˆx,y,z and the estimated uncer-
tainty bˆx,y,z is performed via a fully connected layer with two output neurons
and identity activation.
Loss. The training objective is based on heteroscedastic aleatoric uncertainty
modeling [1], i.e., instead of a single prediction, the model outputs a mean and
a measure of uncertainty per voxel. This effectively corresponds to a probability
distribution per voxel. The loss is given by the negative log-likelihood of the
observed target map data. We choose a Laplace distribution to assign proba-
bilities to observed values since a Gaussian distribution is too light tailed to
cope with the amount of noise in target perfusion maps. Equation 1 formally de-
fines the negative log-likelihood l′, given px,y,z, pˆx,y,z and estimated uncertainty
parameter bˆx,y,z.
l′
(
px,y,z, pˆx,y,z, bˆx,y,z
)
= log bˆx,y,z +
|px,y,z − pˆx,y,z|
bˆx,y,z
(1)
To be able to further focus the networks efforts onto voxel-values of high clinical
importance and to simultaneously reduce the influence of noise, we apply a
weighting scheme to the negative log-likelihood l′ of each voxel. The weighting
scheme is based on a predefined function I that assigns an importance to each
value in P as shown in Equation 2. The weight for a pair (px,y,z, pˆx,y,z) is given
by the function W as shown in Equation 3. The final voxel-wise loss l is given
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by Equation 4. We use an average to compute the loss over multiple voxels.
I(z) =
{
1.0, if 0.0 ≤ z ≤ 40.0
0.1, else
(2)
W (px,y,z, pˆx,y,z) =
max(px,y,z,pˆx,y,z)
max
z=min(px,y,z,pˆx,y,z)
I(z) (3)
l
(
px,y,z, pˆx,y,z, bˆx,y,z
)
= l′
(
px,y,z, pˆx,y,z, bˆx,y,z
)
·W (px,y,z, pˆx,y,z) (4)
Training. The perfusion maps are processed in patches of size 1×32×256, the
perfusion sequences in patches of size 80×1×32×256. These patches are gathered
in batches of size four before being passed to the network. For optimization, we
use Adam [2] with an initial learning rate of 5e−4. The learning rate is divided
by two every four epochs. We rely on dropout regularization with a dropout rate
of 0.5 for fully connected layers and do not use l2-norm weight decay.
3 Experimental Setup and Results
The model was trained and evaluated on DSC-MRI perfusion data of patients
with acute ischemic stroke. For a given perfusion sequence, the target perfusion
maps were generated using oscillation index singular value decomposition in
Olea SphereR© 2.3 with default settings as used in clinical routine. The complete
dataset contains 189 cases, of which we excluded 38 because the detected AIF was
inaccurate, leaving us with a dataset of 151 cases. Approval for this retrospective
study was obtained from the local ethics committee (KEK Bern, Switzerland,
approval number: 231/14). Written informed consent was waived according to
the retrospective nature of this analysis.
We randomly partitioned the dataset into training set, validation set and
test set with ratios of 0.5, 0.2 and 0.3 respectively. The training set was used for
optimizing the network’s weights, the validation set for model selection, and the
test set for evaluating the final model.
The neural network was trained end-to-end, using the pre-processed perfusion
sequences as input and the pre-processed perfusion maps from Olea as target
maps. Training was performed on a Windows machine with an Intel Xeon E5-
1630 v3 @ 3.7GHz and a Nvidia GeForce GTX 1080, and on an Ubuntu machine
with an Intel i7-4790K CPU @ 4.00GHz and two Nvidia GeForce GTX 1070. All
models were trained for 30 epochs, the selection of the final model was based on
its performance on the validation set. The forward propagation took time in the
range of seconds to compute a complete perfusion map.
3.1 Quantitative Results
To quantitatively evaluate and compare different models, we used a mean ab-
solute error with clipping (MAEC) as performance measure. It is identical to a
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Model MAEC@Validation MAEC@Test
Model A 0.513 0.530
− Augmentation (B) 0.531 0.524
− Spatial Correlation (C ) 0.562 0.629
− Bolus Characterization (D) 0.632 0.680
− Loss Weighting (E) 0.683 0.738
Table 1. The MAEC of the predicted Tmax maps for different models. The lines below
model A show the performance of models where the listed component was removed.
mean absolute error, except that voxel-values are clipped to the interval [0, 20]
before computing differences. The clipping was done since values below 0 mostly
correspond to air and the ones above 20 definitely indicate a perfusion deficit or
are part of the noise. The exact values 0 and 20 were chosen because [0, 20] is a
reasonable window for inspecting Tmax maps.
Fig. 3. The influence on the MAEC for different models when shifting the raw perfusion
sequence by a given number of frames.
The model described in Section 2.2 is referred to as model A in the remainder
of this section. Table 2 shows the performance of model A and compares it to
variants of model A where critical components introduced in Section 2.2 were re-
moved. While model A performed best on the validation set, model B performed
best on the test set. When manually inspecting the perfusion sequences of the
validation and test set, we observed that the time of contrast bolus arrival varies
more in the validation set than it does in the test set, with a standard deviation
of 2.76 frames in contrast to 2.09 frames. Hence, the cases in the validation set
did potentially benefit more from data augmentation via temporal shift. How-
ever, this temporal shift made training harder, which made the model perform
slightly worse on cases where the bolus arrival delay was close to the mean de-
lay. To further investigate the effectiveness of our augmentation, we measured
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the MAEC on the validation data for model A and model B after shifting the
perfusion sequences by a number of frames. The results are shown in Figure
3 and clearly indicate that the augmentation successfully helped the model to
compensate for different times of bolus arrival.
Further, we observed that removing the spatial correlation, the bolus char-
acterization structure or the loss weighting significantly decreased the model’s
prediction accuracy on both the validation and the test set. It is evident that
removing loss weighting increases the MAEC, since the loss weights assign high
importance to the values that influence the MAEC.
3.2 Qualitative Results
Figure 4 shows the target map Tmax, the model’s prediction Tˆmax and the esti-
mated variance of the prediction σˆ2 for three samples from the test set.
Fig. 4. The target map Tmax, the predicted map Tˆmax and the estimated variance σˆ
2
of the prediction for three examples from the test set. Note that σˆ2 is given by 2bˆ2.
For the first two cases, the model’s prediction is very close to the target map.
Compared to the target maps, the predictions tend to contain less high-valued
noise and generally have a smoother appearance. We would have expected the
model to predict high uncertainty where its prediction error is likely to be high,
i.e., we would have hoped for a positive correlation between prediction error
and σˆ2. The σˆ2 maps do not match those expectations. Instead, we observed a
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correlation between the predicted value and σˆ2, meaning the prediction of correct
high values seems to be hard for the model. This observation makes sense since
there is a considerable amount of high-valued noise in the target maps.
The third row of Figure 4 shows an example where our model failed. From
observing the corresponding raw perfusion sequence and comparing it to perfu-
sion sequences of examples where the model performed better, we noticed that
the signal attenuation caused by the contrast agent is comparably weak for this
case. Also, the signal is very noisy, partially due to slight head movements, which
are amplified by the low axial resolution of the volumes. Given this additional
information, we assumed that the bolus characterization structure was unable to
correctly capture the bolus arrival in the brain, which led to a poor prediction.
4 Discussion and Conclusion
We made some simplifying assumptions in the presented approach, the most
crucial one being that voxels in a perfusion map mainly depend on the perfusion
sequence of voxels at the same location. This simplification does not always hold,
especially when there was head movement during the sequence acquisition. An
obvious solution to this is to register the individual volumes of the perfusion
sequence before processing them any further. However, this is hard due to the
low resolution of the volumes along the axial axis, which can lead to significant
interpolation artifacts. Furthermore, it does not fit the concept of an end-to-
end learning model. Another possible solution would be to make the sequence
registration part of the model.
In conclusion, we presented a model-free, CNN-based method for inferring
perfusion maps in an end-to-end manner. We demonstrated our method’s per-
formance on an ischemic stroke dataset of 151 patients and have shown that the
predictions are comparable to the target perfusion maps. We are currently work-
ing on a clinical evaluation of the synthetic perfusion maps in order to confirm
the applicability of CNNs in real-world DSC-MRI perfusion imaging.
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Appendix A: Model Hyperparameters
Parameter Name Value
Input Dropout Rate 0.0
Convolutional Dropout Rate 0.5
Fully Connected Dropout Rate 0.0
l2 Weight Decay λ 0.0
Learning Rate 5e−4
Optimizer Adam
Sequence Encoding Dimension 256
Standardize Target Map yes
Standardize Perfusion Sequence yes
Temporal Augmentation Shift ∈ [−5, 30]
Kernel Initializer Xavier Uniform
Activation Function Selu
Batch Normalization no
Error Model Negative Log-Likelihood via
Heteroscedastic Aleatoric Uncertainty
Temporal Smoothing Gaussian with σt = 1.0
Spatial Smoothing no
Table 2. A selection of hyperparameters in consideration, listed together with the
respective value chosen for model A.
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Appendix B: TTP and RBF
(a)
(b)
Fig. 5. (a) The target maps TTP and RBF for three examples in the test set, together
with the prediction of a network trained on the respective target maps. (b) An abstract
outline of the architecture we trained to predict TTP and RBF maps. Compared to
the architecture described in Section 2, the parts in gray were removed. Also, note that
we use a squared loss instead of Laplacian-based negative log-likelihood. We trained
two separate, identical estimators for the two target maps TTP and RBF .
